Cancer treatments, particularly radiation therapy targeting the chest area, can cause inflammation of the lung tissues. Additionally, some chemotherapy agents like bleomycin and immunotherapy drugs such as immune checkpoint inhibitors (e.g., nivolumab and pembrolizumab) have been associated with drug-induced pneumonitis. These treatments can trigger an immune response or direct toxicity to the lung, resulting in inflammation.
